Mycophenolate mofetil for the treatment of scleritis (Q35226436)

7 August 2017

Mycophenolate mofetil for the treatment of scleritis (English)

1 reference

7 August 2017

Robert B. Nussenblatt

5

object named as

Robert B Nussenblatt

1 reference

7 August 2017

1

H Nida Sen

1 reference

7 August 2017

Eric B Suhler

2

1 reference

7 August 2017

Shadi Q Al-Khatib

3

1 reference

7 August 2017

Ali R Djalilian

4

1 reference

7 August 2017

Ronald R Buggage

6

1 reference

7 August 2017

1 September 2003

1 reference

7 August 2017

1 reference

7 August 2017

110

1 reference

7 August 2017

9

1 reference

7 August 2017

1750-1755

1 reference

Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection.

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Use of cyclosporin in the management of steroid dependent non-necrotising scleritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Low-dose methotrexate therapy for ocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Therapy of scleritis with cytotoxic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Mycophenolate mofetil and its mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Bullous pemphigoid treated with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Treatment of pemphigus vulgaris with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Mycophenolate mofetil for severe autoimmune haemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Rescue therapy with mycophenolate mofetil in refractory uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Scleritis and episcleritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Episcleritis and scleritis: clinical features and treatment results

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

Mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900570-0

7 January 2021

10.1016/S0161-6420(03)00570-0

Identifiers

DOI

1 reference

7 August 2017

1 reference